Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol.
Authors
Robbins HA, Callister M, Sasieni P, Quaife SL, Cheung LC, Brennan P, Katki HA, Berg CD, Baldwin D, Johansson M
Affiliations
- International Agency for Research on Cancer, Lyon, France. Electronic address: robbinsh@iarc.fr.
- Leeds Teaching Hospitals, Leeds, UK.
- Kings College London, London, UK.
- University College London, London, UK.
- National Cancer Institute, Rockville, MD, USA.
- International Agency for Research on Cancer, Lyon, France.
- University of Nottingham, Nottingham, UK.
Abstract
N/APublication Details
PubMed ID
31076382
Digital Object Identifier
10.1016/S2213-2600(19)30136-5
Publication
Lancet Respir Med. 2019 Aug; Volume 7 (Issue 8): Pages 655-656